Form 8-K/A · Amended current report
Apollo Global Management 8-K/A, filed Aug 12, 2026
- Filed
- CIK
- 0001858681
- Accession no.
- 0000950142-26-002321
Summary
Following a majority non-binding stockholder vote at its June 8, 2026 annual meeting in favor of annual say-on-pay votes, Apollo Global Management's board of directors decided that future advisory votes on named executive officer compensation will be held every year, starting with the 2027 annual meeting and continuing until the next required advisory vote on say-on-pay frequency, due no later than the 2032 annual meeting.
Key points
- Apollo Global Management stockholders voted on a non-binding, advisory basis at the June 8, 2026 annual meeting in favor of holding a say-on-pay vote every year.
- The board decided future advisory votes on named executive officer compensation will be held annually beginning at the 2027 annual meeting.
- The next advisory vote on the frequency of say-on-pay votes is required no later than the company's 2032 annual meeting.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.07Submission of Matters to a Vote of Security Holders
From the filing
Item 5.07 Submission of Matters to a Vote of Security Holders. As reported in the Original Report, at the Company’s 2026 Annual Meeting of Stockholders held on June 8, 2026, a majority of the Company’s stockholders voted, on a non-binding, advisory basis, in favor of holding a say-on-pay vote every year. Consistent with the preference expressed by the Company’s stockholders, the Company’s Board of Directors has decided that future advisory votes on the compensation of the Company’s named executive officers will be held every year, beginning at the Company’s 2027 Annual Meeting of Stockholders, until the occurrence of the next advisory vote on the frequency of say-on-pay votes, which is…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.